SRS15959059 SAMN31998003 9606 Homo sapiens Homo sapiens male adult (47 years) natural killer primary cell treated with 100 ng/mL Interleukin-12 subunit alpha for 72 hours, 100 ng/mL Interleukin-15 for 72 hours, 100 ng/mL Interleukin-12 subunit beta for 72 hours, 100 ng/mL Interleukin-18 for 72 hours ENCBS311LDY at ENCODE https://www.encodeproject.org/ENCBS311LDY/ Derived from ENCODE donor ENCDO311UBW https://www.encodeproject.org/ENCDO311UBW/ sample type primary cell sex male dev stage adult age 47 year donor ID ENCDO311UBW lab John Stamatoyannopoulos, UW source StemExpress treatments treatment_term_id: UniProtKB:P29459; treatment_term_name: Interleukin-12 subunit alpha; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_id: UniProtKB:P40933; treatment_term_name: Interleukin-15; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_id: UniProtKB:P29460; treatment_term_name: Interleukin-12 subunit beta; treatment_type: protein; duration: 72; duration_units: hour; treatment_term_id: UniProtKB:Q14116; treatment_term_name: Interleukin-18; treatment_type: protein; duration: 72; duration_units: hour; cell type natural killer cell